Long Term Treatment of Multiple Sclerosis with Glatiramer Acetate: Natural History of the Subtypes of Anti-Glatiramer Acetate Antibodies and Their Correlation with Clinical Efficacy

被引:0
|
作者
Brenner, Talma
Teitelbaum, Dvora
Sicsic, Camille
Karussis, Dimitrios
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:A423 / A423
页数:1
相关论文
共 50 条
  • [41] Clinical and immune responses correlate in glatiramer acetate therapy of multiple sclerosis
    Weder, C
    Baltariu, GM
    Wyler, KA
    Gober, HJ
    Lienert, C
    Schluep, M
    Radü, EW
    De Libero, G
    Kappos, L
    Duda, PW
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 (11) : 869 - 878
  • [42] Treatment with glatiramer acetate (Copaxone®) prevents neurodegeneration in patients with multiple sclerosis
    Jaworski, J.
    Leinhard, O. Dahlqvist
    Tisell, A.
    Lundberg, P.
    Landtblom, A. M.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S140 - S141
  • [43] Molecular profiling of glatiramer acetate early treatment effects in multiple sclerosis
    Anat, Achiron
    Anna, Feldman
    Michael, Gurevich
    DISEASE MARKERS, 2009, 27 (02) : 63 - 73
  • [44] Treatment with glatiramer acetate induces specific IgG4 antibodies in multiple sclerosis patients
    Farina, C
    Vargas, V
    Heydari, N
    Kümpfel, T
    Meinl, E
    Hohlfeld, R
    JOURNAL OF NEUROIMMUNOLOGY, 2002, 123 (1-2) : 188 - 192
  • [45] Glatiramer acetate treatment in patients with childhood and juvenile onset multiple sclerosis
    Kornek, B
    Bernert, G
    Balassy, C
    Geldner, J
    Prayer, D
    Feucht, M
    NEUROPEDIATRICS, 2003, 34 (03) : 120 - 126
  • [46] Short-Term Immunosuppression with Mitoxantrone Followed by Long-Term Glatiramer Acetate vs Glatiramer Acetate Alone: Results at 60 Months in Patients with Relapsing Multiple Sclerosis
    Vollmer, Timothy
    Bar-Or, Amit
    Campagnolo, Denise
    Panitch, Hillel
    Arnold, Douglas L.
    NEUROLOGY, 2010, 74 (09) : A544 - A544
  • [47] JNK As a Biomarker of Relapse and Response to Treatment with Glatiramer Acetate in Multiple Sclerosis
    Anselmo, Freidrich
    Tatomir, Alexandru
    Ciriello, Jonathan
    Rus, Horea
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 26 - 26
  • [48] Autoimmune hepatitis in a patient with multiple sclerosis under treatment with glatiramer acetate
    Arruti, Maialen
    Castillo-Trivino, Tamara
    de la Riva, Patricia
    Felix Marti-Masso, Jose
    Lopez de Munain, Adolfo
    Olascoaga, Javier
    REVISTA DE NEUROLOGIA, 2012, 55 (03) : 190 - 192
  • [49] Course of Multiple Sclerosis Associated Fatigue during Treatment with Glatiramer Acetate
    Nowack, Maren
    Rinas, Dagmar
    Limmroth, Volker
    Tettenborn, Barbara
    Putzki, Norman
    NEUROLOGY, 2010, 74 (09) : A421 - A421
  • [50] Long-term therapy with glatiramer acetate in multiple sclerosis: effect on T-cells
    Ragheb, S
    Abramczyk, S
    Lisak, D
    Lisak, R
    MULTIPLE SCLEROSIS JOURNAL, 2001, 7 (01) : 43 - 47